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Abstract
Free radicals have been implicated in the pathogenesis of alcohol-induced liver injury in humans and carbon tetrachloride
 .CCl -induced liver injury in rats. The most extensively studied aspect of free radical induced liver injury is lipid4
peroxidation. Recently it has been found that free radicals can cause oxidative damage to cellular proteins and alter cellular
 .function. One such susceptible protein is the enzyme glutamine synthase GS . The chemical effects of CCl on cell4
proteins and their biological consequences are not known. Hence, in our study, the effect of CCl on liver protein oxidation4
and GS activity were investigated and compared with lipid peroxidation. A significant increase in liver protein carbonyl
 .  .content 2–3 fold and a significant decrease in hepatic GS activity 44–57% were observed. Damage to proteins was rapid
in onset and increased with time. Acute exposure of rats to CCl resulted in an increase in hepatic protein carbonyl content4
and a decrease in hepatic GS within 1 h. In cirrhosis of the liver induced by CCl , the decrease in hepatic GS activity was4
accompanied by a significant increase in plasma ammonia levels. We conclude that protein oxidation may play a role in the
pathogenesis of CCl induced liver injury and that the accumulation of oxidised proteins may be an early indication of CCl4 4
induced liver damage. q 1997 Elsevier Science B.V.
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1. Introduction
Cirrhosis of the liver is one of the major health
problems in developed countries. Cirrhosis of the
liver is the fourth leading cause of death in the
w xAmerican adults 1 , about 70% of which is associ-
Abbreviations: CCl , carbon tetrachloride; GS, glutamine syn-4
thase; PCo, protein carbonyl; LPo, lipid peroxide; MDA, malon-
dialdehyde; TCA, trichloroacetic acid; DNPH, 2,4-di-
 .nitrophenylhydrazine; HEPES, 4- 2-hydroxyethyl 1-piperazine
ethane sulphonic acid; PV, perivenular; AST, aspartate amino-
transferase; ALT, alanine aminotransferase
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ated with alcoholism. Although extensive work is
being done in the field of cirrhosis, the molecular
mechanisms leading to cell death and increased colla-
gen accumulation are still not clear. Therefore, treat-
ment and prevention of the fibrotic process is still
elusive. The most widely accepted animal model of
 .cirrhosis is the ratrcarbon tetrachloride CCl model,4
which is remarkably similar to human alcoholic cir-
w x w xrhosis both histologically 2,3 and systemically 4,5 .
The involvement of free radicals is reported in
both cases. So far, the most extensively investigated
mechanism of free radical induced liver injury is lipid
w xperoxidation 6–9 . Only recently, the possibility that
free radicals may cause potential damage to proteins
0925-4439r97r$19.00 q 1997 Elsevier Science B.V. All rights reserved.
 .PII S0925-4439 97 00065-3
( )P.N. Sundari et al.rBiochimica et Biophysica Acta 1362 1997 169–176170
has been taken into account and a wide range of
w xchanges have been reported 10–12 . The formation
of carbonyl derivatives of proteins is suggested to be
a useful measure of oxidative damage to proteins.
Key metabolic enzymes have been shown to be inac-
tivated by oxygen free radicals produced by either
mixed function oxidase system or by non-enzymatic
w xmethods 13 . The oxidative inactivation of enzymes
by free radicals and the intracellular accumulation of
oxidised proteins may play a critical role in the
alteration of cellular function and cell death. The
chemical effects of CCl on cell proteins and the4
biological consequences of such reactions have not
been studied.
CCl is metabolically activated to free radicals4
 .mainly in perivenular PV hepatocytes which are
rich in the drug metabolising microsomal cytochrome
w xP450 system 14 . GS which plays a pivotal role in
nitrogen metabolism, including detoxification of am-
monia is found exclusively in the PV hepatocytes. It
is in fact considered to be a PV marker enzyme
w x15,16 . Exposure of GS to non-enzymatic mixed
function oxidase system composed of ascorbate, oxy-
 .gen and Fe III has been shown to result in the
oxidative modification of the enzyme. Oxidative
modification of GS abolishes its catalytic activity
w x17,18 . Due to the co-localization of cytochrome
P450 and GS on the microsomes of PV hepatocytes,
it is likely that free radicals generated from CCl by4
cytochrome P450 may cause oxidative inactivation of
GS.
The objectives of the present study were to find
 .out 1 whether oxidation of liver proteins occurs in
 .acute and chronic CCl administration; 2 whether4
 .there is any alteration in hepatic GS activity; and 3
to find out whether there is any relationship between
hepatic GS and plasma ammonia levels.
Our results provide evidence for liver protein oxi-
dation and also for a link between liver protein
 .carbonyl PCo content and the activity of hepatic
GS.
2. Materials and methods
2.1. Animals
Adult male Wistar rats weighing 150–200 g were
used for the study. The rats were housed in gal-
vanised iron cages and maintained on standard labo-
 .ratory rat chow supplied by Lipton India with free
access to tap water in a thermostatically controlled
 .room 288C under 12 h darkrlight cycle.
2.2. Chemicals
2,4-Dinitrophenyl hydrazine, protease inhibitors
leupeptin, pepstatin A, aprotinin and phenylmethyl-
.sulphonyl fluoride , HEPES buffer, ATP, g-glutamyl
hydroxamate, 1,1,3,3-tetramethoxy propane and glu-
tamate dehydrogenase were obtained from Sigma, St.
Louis, MO, USA. All other reagents were of the
highest purity available.
2.3. Animal treatment
2.3.1. Induction of cirrhosis
Cirrhosis was induced in the rats by chronic expo-
sure to CCl vapours according to the method of4
w xMcLean et al. 5 . A wooden box, with a glass front
 .72 = 45 = 46 cm, i.e., 150 l capacity was fitted with
an inlet tap and housed in a fume cupboard. Com-
pressed air was passed via a flow meter, at 4 lrmin,
bubbling through a train of two wash bottles contain-
ing ‘‘Analar’’ CCl maintained at 208C, and into the4
box. Air left the box by leaking through the joints.
CCl was run in for 5 min and was then turned off4
and the rats left in the box for 5 more minutes
 .therefore, total period of 10 min . Treatment was
carried out twice a week for 12 consecutive weeks.
 .Tap water containing phenobarbitone 500 mgrl was
the only source of drinking water for the rats 10 days
prior to the first dose of CCl and throughout the4
treatment period. At the end of 12 weeks, the rats
were sacrificed. Slices of liver tissue were fixed in
10% formalin and processed and stained with haema-
toxylin–eosin, Foot’s reticulin and Van Gieson stains
for histological assessment. The time period of 12
weeks was found to be sufficient to induce cirrhosis
in the rats.
Control rats were kept under the same conditions
as the experimental rats, but were administered phe-
nobarbitone alone.
2.3.2. Acute exposure to CCl4
The rats were administered phenobarbitone in
 .drinking water 500 mgrl for 10 days. The rats were
then exposed to CCl vapours once for a period of4
10 min as described above. The rats were sacrificed at
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the end of various time intervals 2, 4, 8, 14, 18 and
.28 h . In another experiment, the rats were exposed to
 .a low dose of CCl for 6 min instead of 10 min and4
sacrificed after 1 h. Phenobarbitone treated rats served
as controls.
2.4. Biochemical assays
The CCl treated and the control rats were fasted4
overnight before sacrifice. Blood was collected from
the animals under light ether anaesthesia by heart
 .puncture into tubes containing Na EDTA 1 mgrml2
and kept in ice. Plasma was separated immediately
and used for the assay of ammonia and transaminases
 .ALT, AST . The livers were excised quickly,
weighed and used for biochemical and histological
studies. All the assays were carried out within 48 h of
sacrifice of the animals.
2.4.1. Plasma ammonia
Plasma ammonia was estimated enzymatically us-
ing glutamate dehydrogenase and the change in ab-
sorbance of NADPH was monitored spectrophoto-
w xmetrically at 340 nm 19 .
2.4.2. Li˝er protein carbonyl content
About 250 mg of liver was minced and ho-
mogenised in 10 ml of ice-cold 10 mmolrl HEPES
buffer, pH 7.4 containing 125 mmolrl KCl, 5 mmolrl
wNa EDTA and protease inhibitors leupeptin2
 .  .  .0.5 mgrl , pepstatin 0.7 mgrl , aprotinin 0.5 mgrl
 .xand phenylmethylsulphonyl fluoride 40 mgrl to in-
hibit protease activities. PCo content was measured
w xas described by Levine et al. 20 . Aliquots of ho-
mogenate were precipitated with 20% trichloroacetic
 .acid TCA . The pellet was suspended in 10 mmolrl
DNPH in 2 molrl HCl and allowed to stand at room
temperature for 1 h, with vortexing every 10 min.
Proteins were then reprecipitated with 20% TCA and
centrifuged. The pellet was washed thrice with 1 ml
 .of ethanolrethyl acetate 1 : 1 vrv . The final pellet
was dissolved in 1 ml of 6 molrl guanidine hydro-
chloride in 20 mmolrl potassium phosphate buffer
.pH 2.3 . The difference in absorbance of the sample
treated with DNPH in HCl was determined versus the
sample treated with HCl alone at 366 nm. Results are
expressed as nmoles of DNPH incorporatedrmg of Tab
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Fig. 1. Correlation between hepatic PCo content and specific
activity of GS. The regression equation is y s 1.324 y 0.0929 x
 .r s y0.847, P - 0.001 .
protein calculated from an extinction coefficient of
y1 y1 w x21 mM cm for aliphatic hydrazones 21 .
2.4.3. Hepatic glutamine synthase acti˝ity
About 1 g of liver was minced and homogenised in
10 ml of ice-cold HEPES buffer pH 7.4 containing
125 mmolrl KCl and 5 mmolrl Na EDTA. The ho-2
mogenate was sonicated for 30 s at 200 V Vibronics,
.India . The homogenate was centrifuged for 15 min at
16,000 = g at 48C and the supernatant was used for
the determination of GS activity and protein. GS
activity was assayed by the method described by
w xRowe et al. 22 . g-glutamyl hydroxamate was used
as the standard. One unit of enzyme activity is de-
fined as the amount of enzyme catalysing the forma-
tion of 1 mmol of g-glutamyl hydroxamate per hour
at 378C.
2.4.4. Hepatic lipid peroxide le˝els
One gram of liver was homogenised in 9 ml of
 .1.15% ice-cold KCl. Lipid peroxide LPo levels
were measured in whole homogenate by the thio-
w xbarbituric acid reaction 23 . Results are expressed as
 .nmoles of malondialdehyde MDA per gram wet
weight of liver.
Protein was measured by the method described by
Lowry et al. using bovine serum albumin as standard
w x24 .
Fig. 2. Time dependent changes in PCo content, LPo level and
GS activity in rat liver after a single dose CCl .4
2.4.5. Plasma transaminases
 .Plasma aspartate aminotransferase AST and ala-
 .nine aminotransferase ALT activities were assayed
w xas described by Bergmeyer and Bernt 25 .
3. Statistical analysis
All parameters are expressed as mean
values " S.D. Differences between mean values of
tests and controls were evaluated statistically by Stu-
dent’s t-test. A P value of -0.05 was regarded as
Table 2
Hepatic protein carbonyl content, glutamine synthase activity and
plasma transaminase levels 1 h after exposure of rats to low dose
of CCl vapours4
Parameter Control rats CCl treated rats4
 .  .ns6 ns7
aHepatic PCo content 5.10 " 0.16 6.22 "0.44
 .nmolrmg protein
bHepatic GS activity 0.88 " 0.11 0.72 "0.10
 .Urmg protein
 .  .Plasma ALT Url 19.71 " 4.54 20.43 "4.72 ns
 .  .Plasma AST Url 68.17 " 8.42 70.57 "7.66 ns
n s no. of rats. Data represent mean value" SD.
a P - 0.001; b P - 0.05.
Rats were sacrificed 1 h after exposure to CCl vapours for 6 min4
and assays carried out as described in Section 2.
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Fig. 3. Rat liver showing normal appearance and no necrosis 1 h after exposure to low dose of CCl vapours. PT – portal tract, ThV –4
 .terminal hepatic vein. The stain used was hematoxylin–eosin =90 .
 .Fig. 4. Liver cirrhosis in rats treated with CCl for 12 weeks. The stain used was Foot’s reticulin =40 .4
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Table 3
Hepatic protein carbonyl content, lipid peroxide level, glutamine synthase activity and plasma ammonia level in CCl -induced cirrhosis of4
the liver
Parameter Control Cirrhosis
a .  .  .Protein carbonyl content nmolrmg protein 4.12 " 0.39 n s 6 11.19 " 1.02 n s 8
b .  .  .Lipid peroxide level nmolrg wet weight 379.3 " 36.5 n s 7 551.3 " 92.5 n s 8
a .  .  .GS activity Urmg protein 1.00 " 0.21 n s 8 0.43 " 0.10 n s 10
b .  .  .Plasma ammonia level mgr100 ml 122.6 " 26.3 n s 6 262.5 " 77.6 n s 10
nsno. of rats. Data represent mean value " SD.
a P - 0.001; b P - 0.01.
Rats were sacrificed after 12 weeks of treatment with CCl as described in Section 2.4
w xstatistically significant. Karl Pearson’s test 26 was
used for correlation studies.
4. Results
4.1. Acute exposure to CCl4
Table 1 shows the time dependent effect of single
dose of CCl on hepatic PCo content, LPo level, GS4
activity, plasma ammonia level and transaminase lev-
els. A significant increase in PCo content was ob-
 .served approximately 2 fold-28 h value . This was
accompanied by a significant decrease in GS activity
 .44% . A clear significant inverse correlation be-
Fig. 5. Relationship between the specific activity of hepatic GS
and plasma ammonia concentration in cirrhotic rats. The regres-
sion equation y s 522.815 y 661.997x r s y0.819, P -
.0.05 .
tween PCo content and GS activity was observed as
 .shown in Fig. 1 r s y0.847, P - 0.001 . A signif-
icant increase in hepatic MDA levels was also ob-
 .served 7 fold-14 h value . Fig. 2 shows time depen-
dant changes in the above mentioned parameters.
Liver PCo began to rise significantly as early as 2 h
and showed an increase with time. Coincidentally,
hepatic GS activity also began to fall at 2 h and
remained low for 28 h. MDA level showed significant
elevation at 4 h, peaking at 14 h and declining there-
after. There was no significant difference in plasma
ammonia levels between the CCl treated rats and the4
untreated rats. Plasma transaminases began to rise at
8 h, peaked at 14 h and began to decrease thereafter
suggesting that hepatic necrosis had occurred to a
certain extent in the later hours.
In the rats sacrificed 1 h after the low dose of
CCl , the hepatic PCo level was increased by 18%4
and the activity of GS was decreased by 18% as
shown in Table 2. There was no evidence of necrosis
histologically as shown in Fig. 3. Plasma ALT and
AST were unaltered.
4.2. Chronic li˝er injury
The rats that were exposed to CCl vapours for 124
weeks developed cirrhosis as shown in Fig. 4. Table
3 shows the effect of chronic exposure of rats to
CCl on liver PCo, LPo, GS and plasma ammonia4
level. Nearly 3 fold increase in PCo was observed.
GS activity in the cirrhotic rats was decreased signifi-
 .cantly 57% . A moderate, but significant increase in
 .MDA levels 1.5 fold was also observed in the
cirrhotic rats. Plasma ammonia levels were elevated
more than 2 fold in the cirrhotic animals and they
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showed significant inverse correlation with hepatic
GS activity as shown in Fig. 5 r s y0.819, P -
.0.05 .
5. Discussion
It is a well established fact that lipid peroxidation
plays a major role in CCl induced development of4
fatty liver and cirrhosis. Accordingly, we found sig-
nificant increase in the MDA levels 7 fold-14 h
.value upon single exposure to CCl vapours. The4
decrease in MDA levels after 14 h may be due to the
metabolism of MDA by the rat liver mitochondria
w x27 . A significant increase in the PCo content of the
 .liver approximately 2 fold-28 h value was also ob-
served. Nearly 2 fold increase in liver PCo after
single dose of CCl may not appear significant.4
However, it has been estimated that values as low as
2 nmol of carbonyl per mg protein represents damage
w x to about 10% of total cellular proteins 28 these are
minimal values as the oxidative modification of some
amino acid residues in protein does not lead to the
.formation of carbonyl derivatives . Extrapolating from
this, we could calculate that, in CCl treated rats4
about 23% of total hepatocellular proteins are dam-
aged. As mentioned earlier, we found significant
increase in PCo levels even within an hour of expo-
sure to CCl vapours. This suggests that the accumu-4
lation of oxidised proteins in the liver may be an
early indication of CCl induced liver damage.4
Decrease in hepatic GS activity was observed upon
single exposure to CCl vapours. GS is present exclu-4
sively in the PV hepatocytes and is highly susceptible
to oxidative damage by free radicals. The decrease in
GS activity in acute CCl administration may be due4
to the necrosis of PV hepatocytes or due to the
oxidative inactivation of the enzyme. An increase in
PCo content and a decrease in GS of the liver in the
absence of necrosis would suggest oxidative inactiva-
tion of the enzyme. We found a significant increase
in PCo levels and a significant decrease in GS in the
 .liver 1 h after exposure to CCl vapours Table 2 ,4
when there was no evidence of hepatocellular necro-
sis both histologically and biochemically.
Therefore, decreased GS activity in acute CCl4
administration can be attributed to the oxidative inac-
tivation of the enzyme by trichloromethyl radical and
trichloromethylperoxy radical generated from CCl .4
Although significant decrease in hepatic GS was
observed in acute exposure to CCl vapours, plasma4
ammonia levels were unaltered. This could be ex-
plained on the basis of the fact that the other impor-
tant enzymes concerned with the detoxification of
ammonia namely the urea cycle enzymes are mainly
w xperiportal in their location 29 and are reported to be
unaffected by CCl , the PV toxin in short term4
w xexposure of rats 30 .
Regarding chronic liver injury, a greater increase
 .in liver PCo was observed approximately 3 fold
 .compared to acute liver injury approximately 2 fold .
As mentioned earlier values as low as 2 nmolrmg
protein represents damage to about 10% of total
cellular proteins. Extrapolating from this in CCl4
treated rats about 31% of total hepatocellular proteins
are damaged. A 1.5 fold increase in MDA levels was
also observed. Such a low value in MDA levels may
be due to the metabolism of MDA by the rat liver
mitochondria as mentioned earlier.
In chronic liver injury, the decrease in hepatic GS
can be attributed mainly to the loss of functional
hepatocytes. The significant inverse correlation be-
tween plasma ammonia levels and hepatic GS in the
cirrhotic rats suggests that the decrease in the activity
of hepatic GS may contribute to hyperammonemia
observed in the cirrhotic animals, while other factors
such as portosystemic shunting play important roles.
A similar observation has been made earlier by Geb-
w xhardt and Reichen 31 , although they found a greater
 .decrease in GS activity 80% compared to our study
 .57% reduction . These authors have also suggested
that the decrease in GS activity in cirrhosis of the
liver contributes to hyperammonemia.
Our study suggests that oxidative damage to pro-
teins occurs in acute as well as chronic exposure of
rats to CCl and that it may contribute to the patho-4
genesis of liver injury, while lipid peroxidation plays
a major role. Our results also suggest that the accu-
mulation of oxidised proteins in the liver may be an
early indication of CCl liver injury and that the4
decrease in hepatic GS activity in the absence of
.hepatocellular necrosis may be due to the oxidative
inactivation of the enzyme. The decrease in GS activ-
ity in chronic liver injury induced by CCl can be4
attributed to the loss of functional hepatocytes. The
( )P.N. Sundari et al.rBiochimica et Biophysica Acta 1362 1997 169–176176
decrease in GS may contribute to hyperammonemia
observed in cirrhotic animals, while factors such as
portosystemic shunting play important roles.
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